ABSTRACT
The prevention of unplanned 30-day readmissions of patients discharged with a diagnosis of heart failure (HF) remains a profound challenge among hospital enterprises. Despite the many models and indices developed to predict which HF patients will readmit for any unplanned cause within 30 days, predictive success has been meager. Using simulations of HF readmission models and the diagnostics most often used to evaluate them (C-statistics, ROC curves), we demonstrate common factors that have contributed to the lack of predictive success among studies. We reveal a greater need for precision and alternative metrics such as partial C-statistics and precision-recall curves and demonstrate via simulations how those tools can be used to better gauge predictive success. We suggest how studies can improve their applicability to hospitals and call for a greater understanding of the uncertainty underlying 30-day all-cause HF readmission. Finally, using insights from sampling theory, we suggest a novel uncertainty-based perspective for predicting readmissions and non-readmissions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Due to the simulation-based nature of our work and the use of no actual healthcare data, no IRB/oversight body was required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All analyses in our work were performed via computer simulations. No clinical or other data is associated.
